Heron Therapeutics | Spese Operative



Operating Expenses Cambiamento Data
ALKERMES USD 292.72M 25.42M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amarin USD 58.77M 56.06M 2025-03
ANI Pharmaceuticals USD 170.93M 24.02M 2025-03
Arrowhead Research USD 161.51M 2.4M 2025-03
Eisai JPY 189.26B 684M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Insmed USD 340.96M 6.11M 2025-03
Ligand Pharmaceuticals USD 81.55M 29.1M 2025-03
Merck USD 9.66B 1.67B 2025-03
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Pacira USD 166.93M 4.38M 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03
Veracyte USD 113.31M 1.15M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Heron Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.